Senores Pharmaceuticals Increases Stake in Havix Group

Senores Pharmaceuticals Ltd. ( (IN:SENORES) ) has provided an update.

Senores Pharmaceuticals Limited has announced the acquisition of additional equity shares in Havix Group Inc., increasing its direct shareholding from 51.23% to 54.96% and its aggregate shareholding to 70.31%. This strategic move enhances Senores’ control over Havix, potentially strengthening its market position and influence in the pharmaceutical sector. The completion timeline for this acquisition has been adjusted from 10 days to 45 days, providing stakeholders with updated expectations.

More about Senores Pharmaceuticals Ltd.

Senores Pharmaceuticals Limited operates in the pharmaceutical industry, focusing on the development and distribution of pharmaceutical products. The company is based in Ahmedabad, Gujarat, India, and is involved in both domestic and international markets.

YTD Price Performance: -3.50%

Average Trading Volume: 124,303

See more insights into SENORES stock on TipRanks’ Stock Analysis page.